Fainaru M, Schafer Z
Lipid Research Laboratory, Rabin Medical Center, Petah Tiqva, Israel.
Isr Med Assoc J. 2000 Mar;2(3):215-9.
Dyslipidemia and obesity serve as risk factors for the development of atherosclerotic cardiovascular disease. Fasting is sometimes recommended for treating these conditions. This study was undertaken to try to resolve conflicting results reported in the literature.
To study the effect of fasting (0 calories, with free intake of fluids) for 3-5 days on plasma concentration of triglyceride, cholesterol and apolipoprotein B.
Physicians, about to begin a hunger strike, were divided into four groups: normolipidemic non-obese men (group 1), two moderately obese men and two men with type IV hyperlipidemia (group 2), healthy non-obese women (group 3), and healthy non-obese women on oral contraceptives (group 4). Adherence to fasting was monitored daily by detailed interviews, loss of weight, drop in plasma glucose, presence of ketonuria, progressive rise in serum creatinine and uric acid, and decrease in plasma pH. We monitored their serum glucose, electrolytes, liver function, lipids, lipoproteins and apolipoprotein B on days 0, 3, and 5.
Physicians who adhered to complete fasting lost more than 1.5% of their body weight after 3 days of fasting (n = 12), and more than 3.2% at 5 days (n = 5). All non-obese normolipidemic males and females (groups 1 and 3) showed an increase in plasma triglyceride (by 28-162%) and very low density lipoprotein cholesterol (by 22-316%) after 3 days of fasting. The obese and hyperlipidemic men (group 2) showed a decrease of 17-63% in their VLDL cholesterol, and the women on oral contraceptives (group 4) showed a 20% decrease in their plasma triglyceride on day 3. Low density lipoprotein cholesterol increased by 13% in group 2, decreased by 7.3% in group 4, and remained unchanged in group 1 and 3. Apolipoprotein B level correlated well with LDL cholesterol in all groups. High density lipoprotein cholesterol changes were inconsistent.
These results help to explain and reconcile previous published reports. The metabolic background of the individual together with the amount of energy consumed affect the behavior of plasma lipids and lipoproteins levels during fasting.
血脂异常和肥胖是动脉粥样硬化性心血管疾病发生的危险因素。有时建议通过禁食来治疗这些病症。进行本研究旨在解决文献中报道的相互矛盾的结果。
研究禁食(摄入热量为0,可自由饮水)3 - 5天对血浆甘油三酯、胆固醇和载脂蛋白B浓度的影响。
即将开始绝食的医生被分为四组:血脂正常的非肥胖男性(第1组)、两名中度肥胖男性和两名IV型高脂血症男性(第2组)、健康的非肥胖女性(第3组)以及正在服用口服避孕药的健康非肥胖女性(第4组)。通过详细访谈、体重减轻、血浆葡萄糖下降、酮尿症的出现、血清肌酐和尿酸的逐渐升高以及血浆pH值下降来每日监测禁食的依从性。在第0天、第3天和第5天监测他们的血糖、电解质、肝功能、血脂、脂蛋白和载脂蛋白B。
坚持完全禁食的医生在禁食3天后体重减轻超过1.5%(n = 12),在5天后体重减轻超过3.2%(n = 5)。所有血脂正常的非肥胖男性和女性(第1组和第3组)在禁食3天后血浆甘油三酯升高(28% - 162%),极低密度脂蛋白胆固醇升高(22% - 316%)。肥胖和高脂血症男性(第2组)的极低密度脂蛋白胆固醇下降了17% - 63%,服用口服避孕药的女性(第4组)在第3天血浆甘油三酯下降了20%。低密度脂蛋白胆固醇在第2组升高了13%,在第4组下降了7.3%,在第1组和第3组保持不变。在所有组中,载脂蛋白B水平与低密度脂蛋白胆固醇密切相关。高密度脂蛋白胆固醇的变化不一致。
这些结果有助于解释和协调先前发表的报告。个体的代谢背景以及消耗的能量数量会影响禁食期间血浆脂质和脂蛋白水平的变化。